Global ADHD Medication Shortage Sparks Concerns and Substitution Strategies
NHS bosses in the North East are warning about a "worldwide shortage" of ADHD medication, including drugs such as methylphenidate, atomoxetine, lisisdexamfetamine, and guanfacine. The shortage is due to increased global demand and manufacturing problems. NHS leaders are concerned that some patients may not be able to obtain their usual prescriptions. The shortage is expected to resolve at different times between October and the New Year, but there is a possibility that other ADHD drugs may be affected in the coming months. Patients are advised to try alternative pharmacies and consult their GP or ADHD service if they are unable to find the correct medication, as stopping some drugs suddenly can have negative consequences.